ProRx LLC recalls TIRZEPATIDE 60 mg/3mL (20/mg/mL)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- TIRZEPATIDE 60 mg/3mL (20/mg/mL)
- Company
- ProRx LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 1,732 vials
- About this recall
- TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02